Defunct Company
Total Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
964
NCT02349139
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 19, 2015
Completion: Aug 17, 2017
NCT02440685
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Phase: Phase 1/2
Start: May 31, 2015
Completion: Jul 31, 2018
NCT02853643
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
Start: Jul 31, 2016
Completion: Dec 31, 2016
NCT02961283
Study of ASN003 in Subjects With Advanced Solid Tumors
Start: Oct 31, 2016
Completion: Feb 28, 2019
NCT03139981
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
Start: Apr 12, 2017
Completion: Dec 5, 2017
NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors
Start: Jan 19, 2018
Completion: Jun 30, 2020
NCT03531957
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Phase: Phase 2
Start: Jul 5, 2018
Completion: Aug 14, 2019
NCT03654755
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Start: Sep 29, 2018
Completion: Oct 29, 2019
NCT03641573
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
Start: Oct 11, 2018
Completion: Oct 21, 2018
NCT03728504
Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema
Start: Jan 3, 2019
Completion: Apr 29, 2020
NCT03798561
Study to Evaluate ASN008 Topical Gel (TG)
Start: Jan 14, 2019
Completion: Mar 20, 2020
NCT05727709
Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Phase: N/A
Role: Collaborator
Start: Mar 15, 2023
Completion: Jun 30, 2024